Sinovac Biotech Discloses Possible FCPA Violations

Chinese pharmaceutical company Sinovac Biotech disclosed that it is investigating possible violations of the U.S. Foreign Corrupt Practices Act (FCPA). The disclosure is noteworthy because none of the possible violations are believed to have occurred in the United States nor is the company based here.Read the full article